Woman in glasses smiling.

STEP HFpEF study

STEP HFpEF (Semaglutide Treatment Effect in People with Obesity, Heart Failure with Preserved Ejection Fraction)

This study will investigate how well a new drug called semaglutide works at helping people lose weight and reduce symptoms of heart failure.

Participation in the study will last for 59 weeks.

It is being carried out in Greater Manchester by a team cased at the Manchester Heart Centre, part of Manchester University NHS Foundation Trust.

This study has ended and is currently not accepting new applicants.

Trial ID

  • NCT04788511

Share this study